Stockler MR - Search Results

1

Patients' experiences of high-dose-rate brachytherapy boost for prostate cancer using an inpatient protocol.

Hruby G, Chen JY, Bucci J, Loadsman JA, Perry P, Stockler MR. Hruby G, et al. Among authors: stockler mr. Brachytherapy. 2011 Sep-Oct;10(5):395-400. doi: 10.1016/j.brachy.2011.01.008. Epub 2011 Feb 23. Brachytherapy. 2011. PMID: 21345743

2

Randomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatin.

Cox KM, Goel S, O'Connell RL, Boyer M, Beale PJ, Simes RJ, Stockler MR. Cox KM, et al. Among authors: stockler mr. Intern Med J. 2011 Feb;41(2):172-8. doi: 10.1111/j.1445-5994.2010.02201.x. Intern Med J. 2011. PMID: 20214694 Clinical Trial.

3

Patient-reported outcomes of prostate high-dose-rate brachytherapy boost comparing an outpatient and inpatient protocol: a two-center chronologic cohort study.

Chen JY, Hruby G, Stockler MR, Patanjali N, Bucci J, Perez G, Loadsman JA, Sheehan E. Chen JY, et al. Among authors: stockler mr. Brachytherapy. 2011 Nov-Dec;10(6):454-60. doi: 10.1016/j.brachy.2011.03.002. Epub 2011 May 6. Brachytherapy. 2011. PMID: 21550317

4

Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature.

Gzell CE, Kench JG, Stockler MR, Hruby G. Gzell CE, et al. Among authors: stockler mr. Int Urol Nephrol. 2013 Jun;45(3):735-42. doi: 10.1007/s11255-013-0462-7. Epub 2013 May 11. Int Urol Nephrol. 2013. PMID: 23666549 Review.

5

The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study.

Smith AB, King M, Butow P, Luckett T, Grimison P, Toner GC, Stockler M, Hovey E, Stubbs J, Hruby G, Gurney H, Turner S, Alam M, Cox K, Olver I. Smith AB, et al. Psychooncology. 2013 Nov;22(11):2557-64. doi: 10.1002/pon.3323. Epub 2013 Jul 3. Psychooncology. 2013. PMID: 23825010

6

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study.

Smith AB, Butow P, Olver I, Luckett T, Grimison P, Toner GC, Stockler MR, Hovey E, Stubbs J, Turner S, Hruby G, Gurney H, Alam M, Cox K, King MT. Smith AB, et al. Among authors: stockler mr. J Cancer Surviv. 2016 Apr;10(2):223-33. doi: 10.1007/s11764-015-0468-5. Epub 2015 Jul 16. J Cancer Surviv. 2016. PMID: 26178326

7

Measuring men's opinions of prostate needle biopsy.

Medd JC, Stockler MR, Collins R, Lalak A. Medd JC, et al. Among authors: stockler mr. ANZ J Surg. 2005 Aug;75(8):662-4. doi: 10.1111/j.1445-2197.2005.03477.x. ANZ J Surg. 2005. PMID: 16076328

8

Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancer.

Joshua AM, Nordman I, Venkataswaran R, Clarke S, Stockler MR, Boyer MJ. Joshua AM, et al. Among authors: stockler mr. Intern Med J. 2005 Aug;35(8):468-72. doi: 10.1111/j.1445-5994.2005.00883.x. Intern Med J. 2005. PMID: 16176469 Clinical Trial.

9

Screening for prostate cancer: explaining new trial results and their implications to patients.

Barratt AL, Stockler MR. Barratt AL, et al. Among authors: stockler mr. Med J Aust. 2009 Aug 17;191(4):226-9. doi: 10.5694/j.1326-5377.2009.tb02760.x. Med J Aust. 2009. PMID: 19705986

10

A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group.

Moore MM, Stockler M, Lim R, Mok TS, Millward M, Boyer MJ. Moore MM, et al. Cancer Chemother Pharmacol. 2010 Oct;66(5):845-50. doi: 10.1007/s00280-009-1228-x. Epub 2010 Jan 16. Cancer Chemother Pharmacol. 2010. PMID: 20082080 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters